This test is most useful if any of these apply to you.
Your kidneys can lose a surprising amount of function before anything feels wrong. BUN (blood urea nitrogen) is one of the earliest and cheapest signals that something in the kidney-heart-hydration axis is under strain, and its meaning goes well beyond a simple kidney check.
BUN measures the nitrogen part of urea, the main waste product your liver makes from breaking down protein. Your kidneys clear urea out, so the level in your blood reflects how well your kidneys are excreting waste, how much protein you are eating, how hydrated you are, and how much stress your body is under.
BUN is not a kidney-only marker. Its concentration is the balance between how much urea your liver makes and how much your kidneys clear. Liver disease, low protein intake, and malnutrition can pull it down. Dehydration, high protein intake, gastrointestinal bleeding, corticosteroids, catabolic states, and heart failure can push it up.
It also tracks something called neurohormonal activation, meaning the stress-response systems your body uses when circulation is tight. That is why BUN often carries prognostic weight in heart failure and critical illness even after accounting for creatinine and eGFR (a calculation that estimates how well your kidneys filter blood).
In people with moderate to severe chronic kidney disease (stages 3 to 5), higher BUN predicts worse kidney outcomes independent of eGFR. In one prospective study, people in the highest BUN quartile had about 2.66 times the risk of progressing to end-stage kidney disease or dying compared to those in the lowest quartile, and every 10 mg/dL higher BUN carried a 23% higher risk of these composite renal outcomes.
BUN also predicts anemia in non-dialysis CKD, again independent of eGFR. In the KNOW-CKD study, the top BUN quartile carried about 2.13 times the anemia risk of the bottom quartile. This matters because it suggests BUN captures something about kidney stress that filtration rate alone does not.
Heart failure is where BUN has been most rigorously studied as a prognostic marker. A meta-analysis of 19 cohort studies with 56,003 heart failure patients found that people with high BUN had about 2.29 times the mortality risk of those with low BUN, and each one-unit increase carried a 2% higher mortality risk. That signal held whether BUN was analyzed as a category or as a continuous number.
The BUN-to-creatinine ratio adds prognostic depth. In 28,820 chronic heart failure trial participants, a BUN/creatinine ratio at or above the median predicted more hospitalizations and cardiovascular deaths even after adjusting for NT-proBNP (a heart-strain hormone) and eGFR. A rising ratio should prompt a hard look at fluid status and diuretic (water pill) dose.
What this means for you: if you have heart failure or are at risk for it, BUN is not just a kidney number. Treat it as one of the earliest signals that your cardiorenal system (the linked heart and kidney system) is under pressure, and pair it with creatinine, eGFR, and NT-proBNP if available.
In a cohort of 1.34 million US veterans without diabetes, higher BUN (above 25 mg/dL) was linked to a 23% higher risk of developing diabetes, and this held even in people whose kidney filtration was in the normal range. A Chinese study of 211,833 adults found that once BUN crossed a threshold in the reference range, diabetes risk rose by a small amount per unit increase.
This is one of the more surprising findings in the BUN literature. A marker most people associate with kidneys carries independent metabolic information about future diabetes years before glucose starts drifting.
In roughly 26,000 adults followed prospectively, both very low and very high BUN were linked to higher stroke risk. Compared to the middle group, the lowest group had about 21% higher total stroke risk and the highest group had about 16% higher total stroke risk. The pattern held even when BUN stayed within the standard reference range, suggesting the extremes of normal still carry information.
This is the counterintuitive part. If BUN is a waste product, shouldn't lower always be better? Not quite. Very low BUN can reflect low protein intake, malnutrition, or reduced liver capacity to make urea. Very high BUN can reflect impaired kidney clearance, dehydration, catabolism (the body breaking down its own tissues), or bleeding into the gut. BUN is a phenotype marker, not a good-number-bad-number test. Both tails of the distribution can carry risk because they reflect different underlying stresses on the body.
In critical illness, admission BUN carries strong short-term prognostic weight. A 4,176-patient ICU study found that higher admission BUN remained linked to worse outcomes after adjustment for illness severity scores and creatinine. In 9,126 sepsis patients, top-versus-bottom BUN groups had about 2.76 times the 28-day mortality risk, and the association survived adjustment for eGFR.
In COVID-19, admission BUN combined with D-dimer (a clotting-activity marker) predicted in-hospital mortality with an area under the curve of 0.94, and a rise in BUN within 24 hours of admission was linked to sharply higher mortality risk. For most readers, the practical takeaway is not the specific numbers but that BUN adds independent risk information during acute stress.
A single BUN reading can move meaningfully with hydration, a high-protein meal, or a stressful few days. That is exactly why a trend matters more than any one number. Get a baseline. If you make a change to diet, hydration, or medication, retest in 3 to 6 months. If you are healthy and holding steady, at least annually. If you have CKD, heart failure, or diabetes, more often as your clinician recommends.
Read BUN alongside creatinine, eGFR, and cystatin C (a filtration marker less affected by muscle mass) when possible. The BUN-to-creatinine ratio adds context: a ratio pulled higher often points to low fluid volume or catabolism, while a low ratio can hint at low protein intake or liver issues. A trend of drifting BUN, even within the reference range, is often the first thing worth acting on.
BUN moves for many reasons that have nothing to do with kidney damage. The most common ones to know:
Age and sex also matter. Reference data from 24,006 adults showed BUN rises modestly with each decade of age in both men and women, and men have higher median values than women. A single universal cutoff can mislead if your age and sex are not taken into account.
If your BUN comes back higher than expected, the first move is not to panic. Consider the context. Were you well hydrated? Did you have a very high-protein meal the day before? Are you on steroids or diuretics? Retest under standardized conditions: drink water normally, avoid extreme protein loading for a day or two, and hold the draw at a similar time of day as before.
If BUN stays elevated on a repeat draw, review it alongside creatinine, eGFR, cystatin C, urine albumin-to-creatinine ratio, and a basic metabolic panel. A pattern of rising BUN with rising creatinine and falling eGFR points to true kidney function decline and warrants a nephrology conversation. Rising BUN with stable creatinine points more toward low fluid volume, catabolism, or a bleeding source, which is a different workup. A very low BUN with a low albumin points to nutrition or liver issues. Match the pattern to the specialist: nephrologist for kidney patterns, cardiologist for heart failure patterns, gastroenterologist if hidden bleeding is suspected.
BUN is best read as part of a picture, not a verdict. Its power is that it fills in gaps that creatinine and eGFR alone leave open, especially around fluid status, catabolism, and neurohormonal stress. Although BUN is routinely included in standard basic and comprehensive metabolic panels, its prognostic depth beyond kidney function is often underappreciated in day-to-day interpretation, which is why watching its trend still matters.
Evidence-backed interventions that affect your BUN level
BUN is best interpreted alongside these tests.
BUN is included in these pre-built panels.